Physician and Pharmacist Understanding of the Risk of Urinary Retention with Retigabine (Ezogabine): A REMS Assessment Survey
Crossref DOI link: https://doi.org/10.1007/s40801-015-0042-5
Published Online: 2015-10-07
Published Print: 2015-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Ishihara, Lianna
Beck, Melissa
Travis, Sara
Akintayo, Olusegun
Brickel, Neil
Funding for this research was provided by:
GlaxoSmithKline
License valid from 2015-10-07